Mata-Bourcart, L A <br/><br/>
Failure of ketanserin, a serotonin inhibitor, to prevent spontaneous or ergonovine-induced attacks of variant angina.  [electronic resource] 

 -  The Canadian journal of cardiology   
 - 168-71 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0828-282X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angina Pectoris, Variant--diagnosis<br/>Coronary Vasospasm--drug therapy<br/>Dose-Response Relationship, Drug<br/>Electrocardiography<br/>Ergonovine<br/>Female<br/>Humans<br/>Infusions, Parenteral<br/>Ketanserin<br/>Male<br/>Middle Aged<br/>Piperidines--therapeutic use<br/>Serotonin Antagonists--therapeutic use